General Information
Version
6.5
Revision date
2021-04-23
Product name
DAB-buffer tablets for immunohistochemistry
REACH No
This
1.2.1 Relevant identified uses
In vitro diagnostic reagent, Reagent for analysis
Icons in SDS
Company Information
company name
Merck Pty Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H350
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H341 Suspected of causing genetic defects. H350 May cause cancer.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Germ cell mutagenicity (Category 2), H341 Carcinogenicity (Category 1B), H350 For the full text of the H-Statements mentioned in this Section, see Section 16.
